Santhera Pharmaceuticals Operating Profit Margin History
| SANN Stock | CHF 14.84 0.72 5.10% |
Operating Profit Margin captures a dimension of Santhera Pharmaceuticals' financials that revenue and earnings alone do not. The direction of change often matters more than the absolute number.
Latest Santhera Pharmaceuticals' Operating Profit Margin Growth Pattern
Santhera Pharmaceuticals Holding's reported Operating Profit Margin across a 15-year window appears below. Persistent movement in one direction often reflects underlying structural or strategic changes. Reviewing the full arc helps distinguish one-time events from sustained directional shifts. Tracking the rate of change rather than the level itself can surface turning points earlier. The regression line summarizes the overall direction of Santhera Pharmaceuticals' Operating Profit Margin across available periods.
| Operating Profit Margin | 10 Years Trend |
|
Figures are compiled from regulatory filings across reporting cycles.
Operating Profit Margin |
| Timeline |
Operating Profit Margin Trend Statistics
| Arithmetic Mean | -2.58 | |
| Geometric Mean | 2.56 | |
| Coefficient Of Variation | -510.00 | |
| Mean Deviation | 6.44 | |
| Median | -1.74 | |
| Standard Deviation | 13.14 | |
| Sample Variance | 172.77 | |
| Range | 72.3361 | |
| R-Value | 0.48 | |
| Mean Square Error | 142.51 | |
| R-Squared | 0.23 | |
| Significance | 0.05 | |
| Slope | 1.24 | |
| Total Sum of Squares | 2,764 |
Santhera Pharmaceuticals Operating Profit Margin History
| 2026 | -0.81 | ||
| 2025 | -0.77 | ||
| 2024 | -0.85 | ||
| 2023 | 0.67 | ||
| 2022 | -6.96 | ||
| 2021 | 35.67 | ||
| 2020 | -3.54 | ||
| 2019 | -0.14 | ||
| 2018 | -1.62 | ||
| 2017 | -2.2 | ||
| 2016 | -1.74 | ||
| 2015 | 0.73 | ||
| 2014 | -2.9 | ||
| 2013 | -5.54 | ||
| 2012 | -8.81 |
Related Accounts
| Last Reported | End Of Year Estimate | ||
| Other Operating Expenses | -65.2 M | -62 M | |
| Operating Income | -38.4 M | -40.3 M | |
| Total Operating Expenses | 65.2 M | 48.3 M | |
| Total Cash From Operating Activities | -40.9 M | -42.9 M | |
| Change To Operating Activities | 2 M | 1.8 M | |
| Operating Cash Flow Per Share | -2.81 | -2.95 | |
| EV To Operating Cash Flow | -3.99 | -4.19 | |
| Operating Cycle | 622.60 | 591.47 | |
| Price To Operating Cash Flows Ratio | -3.98 | -4.18 | |
| Operating Profit Margin | -0.77 | -0.81 | |
| Operating Cash Flow Sales Ratio | -0.82 | -0.86 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.15 | 1.12 |
Methodology, Assumptions & Data Sources
A look at Santhera Pharmaceuticals's Operating Profit Margin over multiple years is shown here. Checking other line items alongside this one sharpens the picture.
This section for Santhera Pharmaceuticals Holding is built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Values may update on different source schedules. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.